$SPCX

SpaceX Stocks Fall 1.94% Despite Evercore's $275 Price Target

SpaceX (SPCX) shares fell 1.94% to $145.73 on October 16, despite Evercore ISI raising its price target to $275 from $230. The firm maintained an Outperform rating, citing increased 2027 computing-capacity estimates. SpaceX's market cap is $1.98 trillion, with a 15.09 P/B ratio. Investors await evidence of project execution and satellite deployment success to justify valuation.

Original reporting
Published Oct 16, 2026, 8:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SpaceX Stocks Fall 1.94% Despite Evercore's $275 Price Target — source image
Decision brief

The 30-second read

$SPCXNeutralMed
01

Why it matters

The analyst upgrade provides a fresh catalyst, but the share price already slipped, creating mixed short‑term sentiment.

02

Market read

Analyst target change is the primary new information, offering a modest trading angle.

03

What to watch

Financing and timeline for the projected computing capacity remain uncertain.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

SpaceX (NASDAQ:SPCX) is a space, connectivity, and AI firm with a $1.98 trillion market cap. Evercore upgraded its rating and lifted the price target to $275.

Company-level read

Ticker impact

$SPCXNeutralMedium confidence
Context

Evercore raised its price target for SpaceX to $275, prompting a 1.94% share decline.

Expected impact

potential upside as market digests the higher target after the dip

Evidence & confidence

Analyst target change is fresh news; the stock already fell, so short-term pressure exists, but the new $275 target could support a rebound.

Market effects

Raises expectations for the space‑connectivity sector, but no immediate sector‑wide impact.

U.S. market focus; limited regional spillover.

Modest, as SpaceX is a niche player in the global satellite and AI market.

Counterpoint

The target raise may be overly optimistic given execution risks; the stock could face further downside.

Key entities

  • SpaceX

    Space, connectivity and AI company listed on NASDAQ.

  • Evercore ISI

    Investment bank that raised its price target for SpaceX.

Related articles

$SPCXMedAI 8/10

SpaceX Is Changing: Here's What You Need to Know

Space Exploration Technologies (SPCX) is shifting focus toward AI, with CEO Elon Musk predicting $26.5T of its $28.5T market from AI infrastructure. The company launched 165 orbital missions in 2025, but plans to reduce launches in 2026-2027 while introducing the larger Starship rocket. Starlink, its satellite internet service, generated $13.9B in trailing revenue and $5.3B in operating profit, driving SpaceX's plans to expand into mobile carrier services with an $8B spectrum license deal.

$SPCXMed

Why SpaceX Stock Is Sinking Today

SpaceX (SPCX) shares fell 3.5% after CEO Elon Musk's social media posts criticized Ukrainian President Zelensky and discussed Starlink's military service. Starlink, SpaceX's profitable segment, serves 12 million customers and accounts for 60% of revenue. Ukraine reported restrictions on Starlink's service during its conflict with Russia.

$SPCXMed

Why is Space Exploration Technologies stock dropping today?

Space Exploration Technologies (SPCX) stock fell 6.5% to $142.22 due to controversy over Starlink/Starshield restrictions affecting Ukrainian military operations. CEO Elon Musk attributed the restrictions to U.S. government decisions. Barclays predicted a potential Tesla-SpaceX merger, adding uncertainty. The Nasdaq's 1.0% decline further pressured the stock, which hit a session low of $140.66.

$RKLBHighAI 8/10

Rocket Lab Tumbles 11% as Neutron’s First Flight Moves to 2027; SpaceX and AST SpaceMobile Pull Back

Rocket Lab's (RKLB) stock fell 11% after delaying Neutron's first flight to 2027 due to manufacturing issues. SpaceX (SPCX) and AST SpaceMobile (ASTS) also saw declines. Rocket Lab's CEO stated the problem is solved, but testing will extend into Q1 2027. The company's backlog is $2.36 billion, up 137% YoY. Investors are watching for Q3 2026 revenue guidance and test campaign progress.